Skip to main content

Rakuten Medical

Published

Oct 31, 2025

Mickey Mikitani, CEO of Rakuten Medical, sits down with Nasdaq's Kristina Ayanian to discuss his journey from tech to biotech, the promising impact of Rakuten Medical’s cancer therapies, empowering patients and families in their treatment journey, expanding beyond head and neck cancer, and the evolution of the company’s investor base following a $119M Series E raise.

No transcript available

My Quotes
My European Quotes
Watchlist

View as Table

now or see the quotes that matter to you, anywhere on Nasdaq.com. Start browsing Stocks, Funds, ETFs and more asset classes.

/

View as Table

now or see the quotes that matter to you, anywhere on Nasdaq.com. Start browsing Shares, Indexes, ETP and more asset classes.

/

Edit Watchlist

Your Watchlist is empty.

Create your Watchlist to save your favorite quotes on Nasdaq.com. Log in or create a free account to get started.

/